Microbot Medical (MBOT) Institutional Ownership $1.25 +0.03 (+2.46%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$1.21▼$1.2550-Day Range$1.13▼$1.5052-Week Range$1.00▼$4.39Volume30,800 shsAverage Volume53,694 shsMarket Capitalization$14.64 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Microbot Medical (NASDAQ:MBOT)CurrentInstitutional OwnershipPercentage15.22%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$2.45 MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$281,904.96 Get MBOT Insider Trade Alerts Want to know when executives and insiders are buying or selling Microbot Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBOT Institutional Buying and Selling by Quarter Microbot Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2023Wells Fargo & Company MN12,741$35K0.0%+6,713.4%0.157% 8/15/2023Hilltop Holdings Inc.19,075$52K0.0%N/A0.235% 8/11/2023Renaissance Technologies LLC87,695$0.24M0.0%+330.0%1.079% 8/11/2023BlackRock Inc.137,808$0.38M0.0%-9.7%1.695% 8/3/2023Bank of New York Mellon Corp52,738$0.14M0.0%+242.6%0.649% 5/16/2023Armistice Capital LLC600,000$1.25M0.0%-13.0%7.379% Get the Latest News and Ratings for MBOT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. 5/12/2023Dimensional Fund Advisors LP66,207$0.14M0.0%-28.4%0.814% 2/15/2023Armistice Capital LLC690,000$2.08M0.0%N/A0.000% 11/10/2022Dimensional Fund Advisors LP92,451$0.44M0.0%+4.1%0.000% 11/8/2022AlphaCentric Advisors LLC100,000$0.48M0.5%N/A0.000% 8/13/2022Renaissance Technologies LLC20,095$0.10M0.0%+28.0%0.283% 5/16/2022State Street Corp25,270$0.16M0.0%-27.3%0.356% 5/13/2022Renaissance Technologies LLC15,695$98K0.0%+52.5%0.221% 5/12/2022Cetera Advisor Networks LLC12,448$78K0.0%N/A0.175% 5/12/2022Blueshift Asset Management LLC12,841$81K0.0%N/A0.181% 2/25/2022AlphaCentric Advisors LLC100,000$0.75M0.2%N/A1.407% 11/9/2021BlackRock Inc.155,013$1.09M0.0%+11.7%2.181% 8/16/2021State Street Corp34,470$0.27M0.0%N/A0.485% 8/13/2021Renaissance Technologies LLC40,113$0.32M0.0%N/A0.564% 8/12/2021Dimensional Fund Advisors LP53,378$0.42M0.0%N/A0.751% 8/11/2021Bank of New York Mellon Corp15,610$0.12M0.0%-15.0%0.220% 5/21/2021Citadel Advisors LLC16,493$0.14M0.0%N/A0.232% 5/18/2021Millennium Management LLC11,231$96K0.0%N/A0.158% 5/18/2021Citadel Advisors LLC16,493$0.14M0.0%N/A0.232% 5/7/2021BlackRock Inc.194,352$1.65M0.0%+1.3%2.734% 5/7/2021Investment Management Associates Inc. ADV10,000$85K0.0%N/A0.141% 2/17/2021XXEC Inc.92,628$0.64M0.5%-3.3%1.303% 2/11/2021Steward Partners Investment Advisory LLC11,600$80K0.0%-34.1%0.163% 2/10/2021Renaissance Technologies LLC16,200$0.11M0.0%N/A0.228% 2/5/2021BlackRock Inc.191,801$1.32M0.0%+0.8%2.698% 11/13/2020Morgan Stanley3,215$25K0.0%-31.1%0.045% 11/6/2020BlackRock Inc.190,218$1.45M0.0%-11.2%2.678% 10/30/2020Steward Partners Investment Advisory LLC17,600$0.13M0.0%+12.8%0.248% 10/21/2020XXEC Inc.95,810$0.76M0.7%N/A1.349% 5/15/2020Morgan Stanley18,521$0.10M0.0%+353.2%0.261% 5/6/2020Bank of New York Mellon Corp19,698$0.11M0.0%-25.2%0.277% 5/1/2020BlackRock Inc.212,332$1.18M0.0%+16.1%2.989% 4/29/2020Steward Partners Investment Advisory LLC15,600$86K0.0%+420.0%0.220% 2/26/2020Sunbelt Securities Inc.1,602$4.07M0.0%N/A0.026% 2/13/2020Renaissance Technologies LLC188,775$1.92M0.0%-6.3%3.004% 2/4/2020Virtu Financial LLC59,598$0.61M0.1%N/A0.949% 8/14/2019Morgan Stanley6,316$32K0.0%+77.0%0.147% 8/13/2019BlackRock Inc.183,520$0.95M0.0%+5.7%4.260% 8/12/2019Renaissance Technologies LLC206,887$1.07M0.0%+5.5%4.802% 8/7/2019JPMorgan Chase & Co.9,068$45K0.0%N/A0.210% 2/13/2019Geode Capital Management LLC22,151$38K0.0%N/A0.514% 12/13/2018Vanguard Group Inc37,903$0.28M0.0%-91.9%1.272% 11/23/2018Vanguard Group Inc.37,903$0.28M0.0%-91.9%1.272% 9/27/2017Sabby Management LLC1,285,351$1.83M0.1%N/A2.919% 4/11/2017Bank of Montreal Can20,022$0.12M0.0%+90,909.1%0.073% (Data available from 1/1/2016 forward) MBOT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBOT shares? During the previous two years, 11 institutional investors and hedge funds held shares of Microbot Medical. The most heavily invested institutionals were Armistice Capital LLC ($1.25M), AlphaCentric Advisors LLC ($0.48M), BlackRock Inc. ($0.38M), Renaissance Technologies LLC ($0.24M), State Street Corp ($0.16M), Bank of New York Mellon Corp ($0.14M), and Dimensional Fund Advisors LP ($0.14M).Learn more on MBOT's institutional investors. What percentage of Microbot Medical stock is owned by institutional investors? 15.22% of Microbot Medical stock is owned by institutional investors. Learn more on MBOT's institutional investor holdings. Which institutional investors have been buying Microbot Medical stock? Of the 9 institutional investors that purchased Microbot Medical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($0.69M), AlphaCentric Advisors LLC ($0.20M), Renaissance Technologies LLC ($77.10K), Bank of New York Mellon Corp ($37.35K), Hilltop Holdings Inc. ($19.08K), Blueshift Asset Management LLC ($12.84K), and Wells Fargo & Company MN ($12.55K). How much institutional buying is happening at Microbot Medical? Institutional investors have bought a total of 1,064,973 shares in the last 24 months. This purchase volume represents approximately $3.91M in transactions. Which Microbot Medical major shareholders have been selling company stock? The following institutional investors have sold Microbot Medical stock in the last 24 months: Armistice Capital LLC ($90K), Dimensional Fund Advisors LP ($26.25K), BlackRock Inc. ($14.75K), and State Street Corp ($9.50K). How much institutional selling is happening at Microbot Medical? Institutional investors have sold a total of 140,494 shares in the last 24 months. This volume of shares sold represents approximately $0.34M in transactions. Related Companies: Vapotherm Major Shareholders PetVivo Major Shareholders Acorda Therapeutics Major Shareholders T2 Biosystems Major Shareholders NEXGEL Major Shareholders STRATA Skin Sciences Major Shareholders SeaStar Medical Major Shareholders ProSomnus Major Shareholders Organovo Major Shareholders Femasys Major Shareholders This page (NASDAQ:MBOT) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.